A Phase III Randomized Controlled Trial of Azithromycin for RSV-induced Respiratory Failure in Child — Michele Kong (UNIVERSITY OF
Lung disease caused by Respiratory Syncytial Virus (RSV) is associated with substantial short and long-term morbidity for infants and children. Despite this far-reaching disease burden, current manage
| Project title | A Phase III Randomized Controlled Trial of Azithromycin for RSV-induced Respiratory Failure in Child |
|---|---|
| Project number | 5R01HD105678-02 |
| PI name | Michele Kong |
| Institution | UNIVERSITY OF ALABAMA AT BIRMINGHAM |
| Funding mechanism | R01 |
| Agency | NICHD |
| Award amount | $656,356 |
| Fiscal year | 2022 |
| Project start | 2021-08-01T00:00:00 |
| Project end | 2026-07-31T00:00:00 |
| Abstract | Lung disease caused by Respiratory Syncytial Virus (RSV) is associated with substantial short and long-term morbidity for infants and children. Despite this far-reaching disease burden, current manage |
| Key terms | <0-11 years old><3-10C><92-kDa Gelatinase><92-kDa Type IV Collagenase><AMCF-I><Academy><Acute><Acute |
$799/mo
Try GrantRadar →